局部枸橼酸抗凝在肝衰竭患者连续血液净化治疗中的应用进展
Application Progress of Regional Citrate Anticoagulation in Continuous Blood Purification Therapy for Patients with Liver Failure
DOI: 10.12677/ACM.2022.125673, PDF,   
作者: 王亚喜：青岛大学护理学院，山东 青岛；庞旭峰：青岛大学附属医院护理院感部，山东 青岛；林 辉, 潘月帅, 王 刚：青岛大学附属医院重症医学科，山东 青岛
关键词: 肝衰竭；局部枸橼酸抗凝；连续性血液净化；Liver Failure； Regional Citrate Anticoagulation； Continuous Blood Purification Therapy
摘要: 连续性血液净化治疗作为救治肝衰竭患者的重要支持方式之一，为保证其顺利进行，正确合理抗凝至关重要。局部枸橼酸抗凝具有出血风险小、滤器寿命长等显著优势，但肝衰竭患者枸橼酸代谢清除能力下降，发生枸橼酸蓄积等并发症的风险增加故限制了其使用。通过阅读近年来国内外相关文献，就局部枸橼酸抗凝在肝衰竭患者中的安全性、有效性、抗凝风险及评估模型的建立进行综述。
Abstract: For patients with liver failure, continuous blood purification therapy is one of the most important therapeutic methods. It is vital that anticoagulate correctly and reasonably to complete this process smoothly. Regional citrate anticoagulation reduced the risk of bleeding and prolonged the filter lifetime, whereas patients with liver failure had decreased ability of citrate metabolism and in-creased risk complications such as citrate concentration. By reading relevant literature at home and abroad, the review summarized the safety, effectiveness, risk of RCA and evaluation model.
文章引用：王亚喜, 庞旭峰, 林辉, 潘月帅, 王刚. 局部枸橼酸抗凝在肝衰竭患者连续血液净化治疗中的应用进展[J]. 临床医学进展, 2022, 12(5): 4655-4661. https://doi.org/10.12677/ACM.2022.125673

参考文献

[1] Tujios, S.R., Hynan, L.S., Vazquez, M.A., et al. (2015) Risk Factors and Outcomes of Acute Kidney Injury in Patients with Acute Liver Failure. Clinical Gastroenterology and Hepatology, 13, 352-359. [Google Scholar] [CrossRef] [PubMed]
[2] Khwaja, A. (2012) KDIGO Clinical Practice Guidelines for Acute Kidney Injury. Nephron Clinical Practice, 120, c179-c184. [Google Scholar] [CrossRef] [PubMed]
[3] 陈香美. 血液净化标准操作规程[M]. 北京: 人民卫生出版社, 2021.
[4] Schneider, A.G., Journois, D. and Rimmele, T. (2017) Complications of Regional Citrate Anticoagulation: Accumulation or Overload? Critical Care, 21, 281. [Google Scholar] [CrossRef] [PubMed]
[5] Alvarez, G., Chrusch, C., Hulme, T., et al. (2019) Renal Re-placement Therapy: A Practical Update. The Canadian Journal of Anesthesia, 66, 593-604. [Google Scholar] [CrossRef] [PubMed]
[6] 白浪, 陈煜, 陈源文, 等. 人工肝血液净化技术临床应用专家共识(2022年版) [J]. 临床肝胆病杂志, 2022, 28(4): 767-775.
[7] 马元吉, 白浪, 唐红. 局部枸橼酸抗凝在人工肝治疗肝衰竭中的应用研究进展[J]. 中华肝脏病杂志, 2020, 28(6): 532-535. [Google Scholar] [CrossRef] [PubMed]
[8] Yu, Y., Bai, M., Ma, F., et al. (2020) Regional Cit-rate Anticoagulation versus No-Anticoagulation for Continuous Venovenous Hemofiltration in Patients with Liver Fail-ure and Increased Bleeding Risk: A Retrospective Case-Control Study. PLoS ONE, 15, e232516. [Google Scholar] [CrossRef] [PubMed]
[9] 曹燕, 钱丹, 潘红, 等. 枸橼酸抗凝在脓毒症合并肝功能不全患者持续肾脏替代治疗期间的安全性及有效性研究[J]. 中国实用护理杂志, 2019(32): 2488-2491. [Google Scholar] [CrossRef] 
[10] 张春, 林婷, 张靖垚, 等. 局部枸橼酸抗凝在肝切除术后急性肾损伤连续性肾脏替代治疗中临床疗效评价[J]. 中华危重病急救医学, 2018, 30(8): 777-782. [Google Scholar] [CrossRef] [PubMed]
[11] Bernal, W., Lee, W.M., Wendon, J., et al. (2015) Acute Liver Failure: A Curable Disease by 2024? Journal of Hepatology, 62, S112-S120. [Google Scholar] [CrossRef] [PubMed]
[12] Allegretti, A.S., Parada, X.V., Eneanya, N.D., et al. (2018) Prog-nosis of Patients with Cirrhosis and AKI Who Initiate RRT. Clinical Journal of the American Society of Nephrology, 13, 16-25. [Google Scholar] [CrossRef] 
[13] Zarbock, A., Kullmar, M., Kindgen-Milles, D., et al. (2020) Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation during Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality among Critically Ill Patients with Acute Kidney Injury: A Randomized Clinical Trial. JAMA, 324, 1629-1639. [Google Scholar] [CrossRef] [PubMed]
[14] 许俊堂. 肝素诱导的血小板减少症中国专家共识解读[J]. 中国循环杂志, 2018, 33(S2): 117-120. [Google Scholar] [CrossRef] 
[15] 杜然, 曾光. 枸橼酸抗凝对行CRRT治疗的肾衰竭患者凝血指标及肝、肾功能的影响[J]. 国际检验医学杂志, 2020, 41(14): 1717-1719. [Google Scholar] [CrossRef] 
[16] 章颖, 明芳, 薛红. 局部枸橼酸抗凝在肝衰竭患者连续性静脉-静脉血液滤过治疗中的应用[J]. 交通医学, 2021, 35(4): 380-383. [Google Scholar] [CrossRef] 
[17] Weinberg, J.M., Venkatachalam, M.A., Roeser, N.F., et al. (2000) Mitochondrial Dysfunction during Hypoxia/Reoxy- genation and Its Correction by Anaerobic Metabolism of Citric Acid Cycle Intermediates. Proceedings of the National Academy of Sciences of the United States of America, 97, 2826-2831. [Google Scholar] [CrossRef] [PubMed]
[18] Feldkamp, T., Weinberg, J.M., Horbelt, M., et al. (2009) Evidence for Involvement of Nonesterified Fatty Acid-Induced Protonophoric Uncoupling during Mitochondrial Dys-function Caused by Hypoxia and Reoxygenation. Nephrology Dialysis Transplantation, 24, 43-51. [Google Scholar] [CrossRef] [PubMed]
[19] 金源源, 诸炳骅, 费雪洁, 等. 局部枸橼酸抗凝在肝衰竭患者连续性肾脏替代治疗中的应用[J]. 临床肝胆病杂志, 2021, 37(1): 200-203. [Google Scholar] [CrossRef] 
[20] Bagshaw, S.M., Darmon, M., Ostermann, M., et al. (2017) Current State of the Art for Renal Replacement Therapy in Critically Ill Patients with Acute Kidney Injury. Inten-sive Care Medicine, 43, 841-854. [Google Scholar] [CrossRef] [PubMed]
[21] Schultheiss, C., Saugel, B., Phillip, V., et al. (2012) Continuous Venovenous Hemodialysis with Regional Citrate Anticoagulation in Patients with Liver Failure: A Prospective Observa-tional Study. Critical Care, 16, R162. [Google Scholar] [CrossRef] [PubMed]
[22] Zhang, W., Bai, M., Yu, Y., et al. (2019) Safety and Efficacy of Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy in Liver Failure Patients: A Systematic Review and Meta-Analysis. Critical Care, 23, 22. [Google Scholar] [CrossRef] [PubMed]
[23] Ma, Y., Chen, F., Xu, Y., et al. (2019) Safety and Efficacy of Re-gional Citrate Anticoagulation during Plasma Adsorption plus Plasma Exchange Therapy for Patients with Acute-on-Chronic Liver Failure: A Pilot Study. Blood Purification, 48, 223-232. [Google Scholar] [CrossRef] [PubMed]
[24] Rodriguez, K., Srivaths, P.R., Tal, L., et al. (2017) Regional Citrate Anti-coagulation for Continuous Renal Replacement Therapy in Pediatric Patients with Liver Failure. PLoS ONE, 12, e182134. [Google Scholar] [CrossRef] [PubMed]
[25] 宁琪琪, 高原, 段美丽, 等. 局部枸橼酸抗凝在接受连续性肾脏替代治疗的肝病合并急性肾损伤中的应用效果观察[J]. 临床肝胆病杂志, 2020, 36(5): 1055-1058. [Google Scholar] [CrossRef] 
[26] Klingele, M., Stadler, T., Fliser, D., et al. (2017) Long-Term Continuous Renal Replacement Therapy and Anticoagulation with Citrate in Critically Ill Patients with Severe Liver Dysfunction. Critical Care, 21, 294. [Google Scholar] [CrossRef] [PubMed]
[27] Balik, M., Zakharchenko, M., Otahal, M., et al. (2012) Quantifi-cation of Systemic Delivery of Substrates for Intermediate Metabolism during Citrate Anticoagulation of Continuous Re-nal Replacement Therapy. Blood Purification, 33, 80-87. [Google Scholar] [CrossRef] [PubMed]
[28] 樊启晨, 丁峰. 血液净化治疗中局部枸橼酸抗凝时的钙管理[J]. 上海医药, 2018, 39(9): 6-11. [Google Scholar] [CrossRef] 
[29] Zhang, L., Liao, Y., Xiang, J., et al. (2013) Simplified Regional Citrate Anticoagulation Using a Calcium-Containing Replacement Solution for Continuous Venovenous Hemofiltration. Journal of Artificial Organs, 16, 185-192. [Google Scholar] [CrossRef] [PubMed]
[30] Saner, F.H., Treckmann, J.W., Geis, A., et al. (2012) Efficacy and Safety of Regional Citrate Anticoagulation in Liver Transplant Patients Requiring Post-Operative Renal Replacement Therapy. Nephrology Dialysis Transplantation, 27, 1651-1657. [Google Scholar] [CrossRef] [PubMed]
[31] Slowinski, T., Morgera, S., Joannidis, M., et al. (2015) Safety and Efficacy of Regional Citrate Anticoagulation in Continuous Venovenous Hemodialysis in the Presence of Liver Failure: The Liver Citrate Anticoagulation Threshold (L-CAT) Ob-servational Study. Critical Care, 19, 349. [Google Scholar] [CrossRef] [PubMed]
[32] Yu, Y., Peng, S., Cen, Z., et al. (2018) Applying Regional Citrate Anticoagulation in Continuous Renal Replacement Therapy for Acute Kidney Injury Patients with Acute Liver Dysfunction: A Retrospective Observational Study. Kidney and Blood Pressure Re-search, 43, 1065-1074. [Google Scholar] [CrossRef] [PubMed]
[33] 林金锋, 田李均, 王亚东, 等. 肝衰竭患者行局部枸橼酸抗凝连续性肾脏替代治疗时发生枸橼酸蓄积的危险因素分析[J]. 中华危重病急救医学, 2021, 33(2): 211-215. [Google Scholar] [CrossRef] [PubMed]
[34] Ma, Y., Chen, F., Liu, C., et al. (2020) A Novel Predictive Score for Citrate Accumulation among Patients Receiving Artificial Liver Support System Therapy with Regional Citrate Anticoagulation. Scientific Reports, 10, Article No. 12861. [Google Scholar] [CrossRef] [PubMed]
[35] Forsal, I., Nilsson, A., Bodelsson, M., et al. (2021) Mathemati-cal Modelling of Post-Filter Ionized Calcium during Citrate Anticoagulated Continuous Renal Replacement Therapy. PLoS ONE, 16, e247477. [Google Scholar] [CrossRef] [PubMed]

为你推荐